Bio-Thera Solutions Hits Day Low of CNY 20.15 Amid Price Pressure

Bio-Thera Solutions, a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 6.93%. The stock reached an intraday low of CNY 20.15, reflecting ongoing challenges in its financial performance. Over the past week, Bio-Thera has seen a decrease of 8.79%, and its performance over the last month shows a decline of 13.29%. In terms of annual performance, the stock has managed a modest gain of 4.37% over the past year, but this is notably below the 13.33% increase seen in the China Shanghai Composite index. Year-to-date, Bio-Thera's performance is down 11.19%, and it has underperformed the index over the last three years, with a decline of 19.66%. Key financial metrics indicate concerns, including a low Return on Capital Employed (ROCE) of 1.31% and a high debt-equity ratio of 79.01%. The company has reported negative results for the last three consecutive quarters, further highlighting its current financial difficulties.